Journal
Clinical infectious diseases
Publication Date
2-5-2025
Volume
80
Issue
1
First Page
43
Last Page
51
Document Type
Open Access Publication
DOI
10.1093/cid/ciae437
Rights and Permissions
Paul Feuerstadt, Teena Chopra, Whitfield Knapple, Nicholas W Van Hise, Erik R Dubberke, Brian Baggott, Beth Guthmueller, Lindy Bancke, Michael Gamborg, Theodore S Steiner, Daniel Van Handel, Sahil Khanna, PUNCH CD3-OLS: A Phase 3 Prospective Observational Cohort Study to Evaluate the Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA) in Adults With Recurrent Clostridioides difficile Infection, Clinical Infectious Diseases, Volume 80, Issue 1, 15 January 2025, Pages 43–51, https://doi.org/10.1093/cid/ciae437. https://academic.oup.com/cid/article/80/1/43/7740543?login=true. © The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Recommended Citation
Feuerstadt, Paul; Chopra, Teena; Knapple, Whitfield; Van Hise, Nicholas W; Dubberke, Erik R; Baggott, Brian; Guthmueller, Beth; Bancke, Lindy; Gamborg, Michael; Steiner, Theodore S; Van Handel, Daniel; and Khanna, Sahil, "PUNCH CD3-OLS: A phase 3 prospective observational cohort study to evaluate the safety and efficacy of fecal microbiota, live-jslm (REBYOTA) in adults with recurrent Clostridioides difficile infection." Clinical infectious diseases. 80, 1. 43 - 51. (2025).
https://digitalcommons.wustl.edu/oa_4/4804
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
